Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
John Choi, Ravi Medikonda, Laura Saleh, Timothy Kim, Ayush Pant, Siddhartha Srivastava, Young-Hoon Kim, Christina Jackson, Luqing Tong, Denis Routkevitch, Christopher Jackson, Dimitrios Mathios, Tianna Zhao, Hyerim Cho, Henry Brem & Michael Lim. (2021) Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma. OncoImmunology 10:1.
Read now
Read now
Xiangmin Li, Zhaoguo Xu, Guoyuan Cui, Li Yu & Xiaoye Zhang. (2020) BTLA Expression in Stage I–III Non–Small-Cell Lung Cancer and Its Correlation with PD-1/PD-L1 and Clinical Outcomes. OncoTargets and Therapy 13, pages 215-224.
Read now
Read now
Nadishka Jayawardena, Laura N Burga, John T Poirier & Mihnea Bostina. (2019) Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development. Oncolytic Virotherapy 8, pages 39-56.
Read now
Read now
Livius Penter, Kerstin Dietze, Julia Ritter, Maria Fernanda Lammoglia Cobo, Josefin Garmshausen, Felix Aigner, Lars Bullinger, Holger Hackstein, Sandra Wienzek-Lischka, Thomas Blankenstein, Michael Hummel, Klaus Dornmair & Leo Hansmann. (2019) Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer. OncoImmunology 8:6.
Read now
Read now
Benjamin Bian, Daniele Fanale, Nelson Dusetti, Julie Roque, Sonia Pastor, Anne-Sophie Chretien, Lorena Incorvaia, Antonio Russo, Daniel Olive & Juan Iovanna. (2019) Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma. OncoImmunology 8:4.
Read now
Read now
Kazuhiro Mochizuki, Satoshi Kawana, Shoki Yamada, Moe Muramatsu, Hideki Sano, Shogo Kobayashi, Yoshihiro Ohara, Nobuhisa Takahashi, Michiyuki Hakozaki, Hitoshi Yamada, Yuko Hashimoto & Atsushi Kikuta. (2019) Various checkpoint molecules, and tumor-infiltrating lymphocytes in common pediatric solid tumors: Possibilities for novel immunotherapy. Pediatric Hematology and Oncology 36:1, pages 17-27.
Read now
Read now
Articles from other publishers (55)
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, Ana P. Gonzalez-Rodriguez, Ángel R. Payer, Esther González-García, Candelaria Aguilar-García, Sara González-Rodríguez, Alejandro López-Soto, Alejandra García-Torre & Segundo Gonzalez. (2023) BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia. Cancer Immunology, Immunotherapy 72:7, pages 2529-2539.
Crossref
Crossref
Ping Yan, Mingjing Cheng, Li Wang & Weidong Zhao. (2023) A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach. International Immunopharmacology 119, pages 110263.
Crossref
Crossref
Clémence Demerlé, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frédéric Fiore, Jacques A Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Hervé Luche, Fabrice Barlesi & Daniel Olive. (2023) Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors. Journal for ImmunoTherapy of Cancer 11:5, pages e006348.
Crossref
Crossref
Maria-Luisa del Rio, Carla Yago-Diez de Juan, Giovanna Roncador, Eduardo Caleiras, Ramón Álvarez-Esteban, José Antonio Pérez-Simón & Jose-Ignacio Rodriguez-Barbosa. (2023) Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression. Frontiers in Immunology 14.
Crossref
Crossref
Anna Andrzejczak, Anna Partyka, Andrzej Wiśniewski, Irena Porębska, Konrad Pawełczyk, Kuba Ptaszkowski, Piotr Kuśnierczyk, Monika Jasek & Lidia Karabon. (2023) The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in Immunology 13.
Crossref
Crossref
Kelsey E. Huntington & Wafik S. El-Deiry. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
44
.
Tian-You Cheng, Ya-Juan Liu, Hong Yan, Yi-Bo Xi, Li-Qiang Duan, Yang Wang, Tian-Tian Zhang, Yin-Min Gu, Xiao-Dong Wang, Chang-Xin Wu & Shan Gao. (2022) Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2. Cells 11:24, pages 4021.
Crossref
Crossref
Meenakshi Gupta, Kumari Chandan & Maryam Sarwat. (2022) Natural products and their derivatives as immune check point inhibitors: Targeting cytokine/chemokine signalling in cancer. Seminars in Cancer Biology 86, pages 214-232.
Crossref
Crossref
Kyung-Soo Chun, Do-Hee Kim, Pawan Kumar Raut & Young-Joon Surh. (2022) Anticancer natural products targeting immune checkpoint protein network. Seminars in Cancer Biology 86, pages 1008-1032.
Crossref
Crossref
Jun Lei, Guifeng Zhang, Deyu Li, Jiangming Zhong, Qiao Chen, Li Lin & Zhenhua Liu. (2022) Analysis of exosomal competing endogenous RNA network response to paclitaxel treatment reveals key genes in advanced gastric cancer. Frontiers in Oncology 12.
Crossref
Crossref
Paraskevi Kogionou, Sotirios Fortis, Maria Goulielmaki, Nicolas Aubert, Panagiota Batsaki, Sotirios Ouzounis, Dionisis Cavouras, Gilles Marodon, Savvas Stokidis, Angelos Gritzapis & Constantin Baxevanis. (2022) Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 14:20, pages 5032.
Crossref
Crossref
Xin Hu, Liuxing Wu, Yanxin Yao, Junfu Ma, Xiangchun Li, Hongru Shen, Luyang Liu, Hongji Dai, Wei Wang, Xinlei Chu, Chao Sheng, Meng Yang, Hong Zheng, Fengju Song, Kexin Chen & Ben Liu. (2022) The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance. iScience 25:10, pages 105075.
Crossref
Crossref
Lu Yu, Minghan Sun, Qi Zhang, Qiao Zhou & Yi Wang. (2022) Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Anna Kuzevanova, Natalya Apanovich, Danzan Mansorunov, Alexandra Korotaeva & Alexander Karpukhin. (2022) The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. Biomedicines 10:9, pages 2081.
Crossref
Crossref
Jian Chen, Jun Wang, Ruihao Liu, Haiwei Xiong, Yingying Liu, Mingzhi Zha, Qiang Li, Xuan Liu, Mingjun Shang & Yingliang Li. (2022) The correlation of BTLA rs1982809 polymorphism with cancer susceptibility: A meta-analysis of 8634 participators. Medicine 101:31, pages e29610.
Crossref
Crossref
Maryam Azarafza, Mohsen Tehrani, Reza Valadan, Iradj Maleki, Seyed Mohammad Mehdi Ghaffari-Hamedani, Alireza Ghanadan, Reza Alizadeh-Navaei & Abolghasem Ajami. (2022) Role of BTLA/HVEM network in development of gastric cancer. Human Immunology 83:8-9, pages 637-644.
Crossref
Crossref
Karolina Wojciechowicz, Marta Spodzieja, Katarzyna A. Lisowska & Anna Wardowska. (2022) The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases. Cellular Immunology 376, pages 104532.
Crossref
Crossref
Paul David, Jaana Westmeier, Malgorzata Drabczyk-Pluta, Tanja Werner, Julia Ickler, Sandra Francois, Wibke Bayer, Kathrin Sutter, Maria Luisa Del Rio, Jose-Ignacio Rodriguez-Barbosa, Ulf Dittmer & Gennadiy Zelinskyy. (2022) The Role of the Inhibitory Ligand HVEM and Its Receptors CD160 and BTLA in the Regulation of Anti-retroviral T Cell Responses. Frontiers in Virology 2.
Crossref
Crossref
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, Doriana Fruci & Federica Gemignani. (2022) News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Seminars in Cancer Biology 79, pages 18-43.
Crossref
Crossref
Xianzhe Yu, Shan He, Jian Shen, Qiushi Huang, Peng Yang, Lin Huang, Dan Pu, Li Wang, Lu Li, Jinghua Liu, Zelong Liu & Lingling Zhu. (2022) Tumor vessel normalization and immunotherapy in gastric cancer. Therapeutic Advances in Medical Oncology 14, pages 175883592211101.
Crossref
Crossref
Di Zhu & Fenglian He. 2022.
Wataru Murase, Yukino Kamakura, Serina Kawakami, Ayaka Yasuda, Momoka Wagatsuma, Atsuhito Kubota, Hiroyuki Kojima, Tohru Ohta, Mami Takahashi, Michihiro Mutoh, Takuji Tanaka, Hayato Maeda, Kazuo Miyashita & Masaru Terasaki. (2021) Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells. International Journal of Molecular Sciences 22:24, pages 13620.
Crossref
Crossref
Sai Mummareddy, Stuti Pradhan, Ashwin Narasimhan & Arutselvan Natarajan. (2021) On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy. Biosensors 11:12, pages 500.
Crossref
Crossref
Jianhua Wang, Ping Xu, Yanping Hao, Tingting Yu, Limin Liu, Yan Song & Yan Li. (2021) Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression. BMC Cancer 21:1.
Crossref
Crossref
Sheera R. Rosenbaum, Manoela Tiago, Signe Caksa, Claudia Capparelli, Timothy J. Purwin, Gaurav Kumar, McKenna Glasheen, Danielle Pomante, Daniel Kotas, Inna Chervoneva & Andrew E. Aplin. (2021) SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects. Cell Reports 37:10, pages 110085.
Crossref
Crossref
Rui-Peng Zhao, Zhi Li, Chang Li, Kang Xu, Lin-Lin Zhen, Wei Song & Jian-Hua Shi. (2021) A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women. Clinical Breast Cancer 21:5, pages e512-e517.
Crossref
Crossref
Clemence Demerlé, Laurent Gorvel & Daniel Olive. (2021) BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2021) Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Zhaohao Huang, Binyao ChenXiuxing LiuHe LiLihui XieYuehan GaoRunping Duan, Zhaohuai Li, Jian Zhang, Yingfeng ZhengWenru Su. (2021) Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proceedings of the National Academy of Sciences 118:33.
Crossref
Crossref
Saber Mehdizadeh, Hashem Bayatipoor, Salar Pashangzadeh, Roghayeh Jafarpour, Zeinab Shojaei & Morteza Motallebnezhad. (2021) Immune checkpoints and cancer development: Therapeutic implications and future directions. Pathology - Research and Practice 223, pages 153485.
Crossref
Crossref
Nicolas Aubert, Simon Brunel, Daniel Olive & Gilles Marodon. (2021) Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice. Cancers 13:12, pages 3009.
Crossref
Crossref
Zheng Deng, Yi Zheng, Pei Cai & Zheng Zheng. (2021) The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Nina Zila, Christoph Hoeller & Verena Paulitschke. (2021) Novel immune checkpoints beyond PD-1 in advanced melanoma. memo - Magazine of European Medical Oncology 14:2, pages 135-142.
Crossref
Crossref
Claudia Cocco, Fabio Morandi & Irma Airoldi. (2021) Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes. Cells 10:4, pages 927.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto & Segundo Gonzalez. (2021) BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia. Cancers 13:8, pages 1766.
Crossref
Crossref
Ali Safarzadeh, Mohsen Alizadeh, Fatemeh Beyranvand, Reza Falavand Jozaaee, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antonella Argentiero, Behzad Baradaran & Nicola Silvestris. (2020) Varied functions of immune checkpoints during cancer metastasis. Cancer Immunology, Immunotherapy 70:3, pages 569-588.
Crossref
Crossref
Matthew J. Cascio, Elizabeth M. Whitley, Bikash Sahay, Galaxia Cortes-Hinojosa, Lung-Ji Chang, Jonathan Cowart, Marc Salute, Elias Sayour, Michael Dark, Zachary Sandoval, Duane A. Mitchell & Rowan J. Milner. (2021) Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate. Veterinary Immunology and Immunopathology 232, pages 110169.
Crossref
Crossref
Saeid Taghiloo & Hossein Asgarian-Omran. (2021) Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways. Critical Reviews in Oncology/Hematology 157, pages 103164.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, A.P. González-Rodríguez & Segundo González. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
267
304
.
R. R. Maniyar, S. Chakraborty, T. Jarboe, R. Suriano, M. Wallack, J. Geliebter & R. K. Tiwari. 2021. Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions. Tumor Microenvironment: Cellular, Metabolic and Immunologic Interactions
123
143
.
Katarzyna Kuncewicz, Claire Battin, Adam Sieradzan, Agnieszka Karczyńska, Marta Orlikowska, Anna Wardowska, Michał Pikuła, Peter Steinberger, Sylwia Rodziewicz-Motowidło & Marta Spodzieja. (2020) Fragments of gD Protein as Inhibitors of BTLA/HVEM Complex Formation - Design, Synthesis, and Cellular Studies. International Journal of Molecular Sciences 21:22, pages 8876.
Crossref
Crossref
Salman M. Toor, Varun Sasidharan Nair, Julie Decock & Eyad Elkord. (2020) Immune checkpoints in the tumor microenvironment. Seminars in Cancer Biology 65, pages 1-12.
Crossref
Crossref
Shuchen Chen, Rui Cao, Chao Liu, Weifeng Tang & Mingqiang Kang. (2020)
Investigation of
IL-4, IL-10
, and
HVEM
polymorphisms with esophageal squamous cell carcinoma: a case–control study involving 1929 participants
. Bioscience Reports 40:8.
Crossref
Crossref
Maria Grazia Refolo, Claudio Lotesoriere, Caterina Messa, Maria Gabriella Caruso & Rosalba D'Alessandro. (2020) Integrated immune gene expression signature and molecular classification in gastric cancer: New insights. Journal of Leukocyte Biology 108:2, pages 633-646.
Crossref
Crossref
Marta Spodzieja, Katarzyna Kuncewicz, Adam Sieradzan, Agnieszka Karczyńska, Justyna Iwaszkiewicz, Valérie Cesson, Katarzyna Węgrzyn, Igor Zhukov, Martyna Maszota-Zieleniak, Olivier Michielin, Daniel E. Speiser, Vincent Zoete, Laurent Derré & Sylwia Rodziewicz-Motowidło. (2020) Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding. International Journal of Molecular Sciences 21:2, pages 636.
Crossref
Crossref
Weifeng Tang, Shuchen Chen, Mingqiang Kang, Jun Liu & Chao Liu. (2019)
Investigation of
BTLA
tagging variants with risk of esophagogastric junction adenocarcinoma
. Bioscience Reports 39:12.
Crossref
Crossref
Yu-Chen S.H. Yang, Zi-Lin Li, Ya-Jung Shih, James A. Bennett, Jaqueline Whang-Peng, Hung-Yun Lin, Paul J. Davis & Kuan Wang. (2019) Herbal Medicines Attenuate PD-L1 Expression to Induce Anti-Proliferation in Obesity-Related Cancers. Nutrients 11:12, pages 2979.
Crossref
Crossref
Qinchuan Wang, Jinhua Zhang, Huakang Tu, Dong Liang, David. W. Chang, Yuanqing Ye & Xifeng Wu. (2019) Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Chia-Cheng Lin, Yu-Tang Chin, Ya-Jung Shih, Yi-Ru Chen, Yao-Yu Chung, Chi-Yu Lin, Chao-Nan Hsiung, Jacqueline Whang-Peng, Sheng-Yang Lee, Hung-Yun Lin, Paul J. Davis & Kuan Wang. (2019) Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells. Journal of Dental Sciences 14:3, pages 255-262.
Crossref
Crossref
Ming-Zhi Han, Shuai Wang, Wen-Bo Zhao, Shi-Lei Ni, Ning Yang, Yang Kong, Bin Huang, An-Jing Chen, Xin-Gang Li, Jian Wang & Dong-Hai Wang. (2019) Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma. EBioMedicine 43, pages 159-170.
Crossref
Crossref
David J. Zahavi & Louis M. Weiner. 2019. Cancer Immunotherapy. Cancer Immunotherapy
61
100
.
Qianyu Guo, Fan Huang, Christophe Goncalves, Sonia V. del Rincón & Wilson H. MillerJrJr. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer
1
62
.
John R. Šedý & Parham Ramezani-Rad. 2019.
145
186
.
Julian A. Marin-Acevedo, Bhagirathbhai Dholaria, Aixa E. Soyano, Keith L. Knutson, Saranya Chumsri & Yanyan Lou. (2018) Next generation of immune checkpoint therapy in cancer: new developments and challenges. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka, Shinichiro Hiraiwa, Sakura Tomita, Haruka Ikoma, Yusuke Kondo, Sawako Shiraiwa, Kiyoshi Ando, Shinji Sato, Yasuo Suzuki, Ikuo Miura, Giovanna Roncador & Naoya Nakamura. (2018) Genomic Profile and Pathologic Features of Diffuse Large B-Cell Lymphoma Subtype of Methotrexate-associated Lymphoproliferative Disorder in Rheumatoid Arthritis Patients. American Journal of Surgical Pathology 42:7, pages 936-950.
Crossref
Crossref